A team of scientists has found that an existing cancer drug could be repurposed to target a subset of cancers that currently lack targeted treatment options and is often associated with poor outcomes. This subset of cancers makes up 15 per cent of all cancers and is especially prevalent in aggressive tumors such as osteosarcoma (bone tumor) and glioblastoma (brain tumor).
Tourists delighted as pinnipeds congregate at city’s Pier 39, apparently attracted by feast of anchovies
Cities are frustrated by 911 calls from senior facilities to help residents off the floor or toilet. Some are now charging fees, but facilities keep…
When the U.S. government’s spending bills for this fiscal year were belatedly finalized in March, the U.S. National Institutes of Health (NIH) largely escaped the…
Stevie Ray Vaughan Acoustic Guitar Solo- RARE Video Footage
Nature – It can be hard when junior scientists feel unsupported. Nature asked three scientists for their advice on how to respond.
Nature – Quantitative multimodal 3D reconstruction of human pancreatic tissue at single-cell resolution reveals a high burden of multifocal, genetically heterogeneous pancreatic intraepithelial…
Cancers can’t develop without genetic mutations — or can they? Key Takeaways • Cancer cells develop from genetic mutations in DNA. • However, a new…
Guevara-Aguirre et al. evaluated the cardiovascular disease risk factors in individuals with Laron syndrome and their relatives to identify the effects of decreased growth hormone signaling…
Upon a diagnosis, the clinical team faces two main questions: what treatment, and at what dose? Clinical trials’ results provide the basis for guidance and…
Nature Communications – CAR T cell immunotherapy for paediatric solid and brain tumours is constrained by the availability of targetable antigens. Here, the authors investigate…
